NAS10026,906−5.38%S&P7,400−3.75%GOLD$4,127+1.33%BTC$76,159−5.28%VIX24.13+45.27%latest tape · as of 20:03 UTC
The Screen · Technology · Electronic Components
APHAmphenol
APH · a US exchange · USD · Market cap $202.4B · 170,000 employees
Amphenol Corporation, together with its subsidiaries, designs, manufactures, and markets electrical, electronic, and fiber optic connectors in the United States, China, and internationally.
FAIL · Does not pass the screen
79.01 USD
Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price79.01 USD at the 4 Nov 2026 close
Our value readUndervalued vs our fair value, as of 4 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.43, read 2026-11-01
Ethical does not pass the values gate
Price79.01 USD
Fair value98.27
Ethical score10.0/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-10-26Read Distribution81.49-3.0% to today ✓Markdown gives way to Distribution
2026-10-21Read Markdown81.49-3.0% to today ✓Accumulation gives way to Markdown with results news in the headlines
2026-10-18Read Accumulation81.49-3.0% to today Markup gives way to Accumulation
2026-10-11Read Markup84.09-6.0% to today Distribution gives way to Markup first Markup read since August
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Amphenol holds its Distribution at $79.01. Consolidating, no directional conviction, held for 21 days.
As held on the ledger · 2026-11-04
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 21 days
Price at the screen
$79.01
Valuation
35.53 trailing · 23.31 forward price to earnings
Values screen
FAIL· score 10.0
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
42.78%
Below 33%
Interest-bearing debt is 42.8% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.84%
Below 33%
Cash held in interest-bearing accounts and securities is 0.8% of assets, under the one-third limit.
Pass
Receivables
43.73%
Below 49%
Money owed to the company is 43.7% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Amphenol's business is in a permissible area, but its interest-bearing debt is about 43% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when APH's ethical verdict changes
Today APH does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly a 20% discount to our $98.27 fair value, moderate competitive moat, 65.10% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 19.6% discount to the base estimate.
Where our models see it going: fair-value estimate $98.27, with a range of $76.50 to $114.43, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Amphenol's Debt Drags Despite Strong Growth
Imagine a world where connectivity is key, and Amphenol is the silent backbone, providing the connectors that make it happen. With a robust 55% revenue growth and a healthy profit margin of 18%, Amphenol stands out for its role in the technology and electronic components sector. Despite its position in a critical industry and a forward P/E of 23.8x, which suggests a reasonable valuation, the company's debt ratio fails our ethical screen.
While Amphenol's ROE of 38% indicates strong returns on equity and its moderate moat suggests it has some competitive advantage, the ethical failing on debt ratio is a significant red flag. Despite 17 analysts giving it a strong buy consensus with a median target of $197, the underlying financial health concerns can't be ignored. This is particularly important in an industry where stability and trust are paramount.
Risk lies in Amphenol's debt levels, which are high enough to fail our ethical screening process. This is not a matter of business performance but of financial prudence and sustainability. Given this, despite the attractive growth and potential, our analysis leads us to avoid Amphenol. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
APH trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Distribution$84.19+3.3%Entry 25
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182.
2026-10-28Distribution$81.49+0.0%Entry 24
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Distribution$81.49+0.0%Entry 23
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markdown$81.49+0.0%Entry 21
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markdown$81.49+0.0%Entry 20
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markdown$81.49+0.0%Entry 19
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markdown$81.49+0.0%Entry 18
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markdown · changed$81.49+0.0%Entry 17
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.